Enosium Life Science acquires RWEality
Ella Day | April 3, 2025 | News story | Business Services, Consultancy |Â Â Consultancy, Corporate, Enosium Life Sciences, RWEality, acquisition, life sciences, research and developmentÂ
Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on public policies, technology and healthcare practices.
Founded in 2024, Enosium is a multi-specialist group which provides scientific services for the European life sciences market. It offers clinical research, regulatory affairs, medical affairs, market access and marketing to pharma and biotech companies. This acquisition indicates a significant landmark in Enosium’s commitment to building a group that spans the value chain of healthcare products.
RWEality is a research and consulting firm specialising in the evaluation of public policies, technologies and healthcare practices. In particular, it focuses on using real-world data to do this.
This strategic acquisition strengthens Enosium’s capabilities in market access and data valuation for healthcare products. RWEality consultants will reinforce and complement Enosium’s existing team of specialists in European market access, medical communication, and health economics and outcomes research (HEOR).
Antoine Amer, founder and chief executive officer (CEO) of Enosium, stated: “I am very pleased to welcome Sandrine Bourguignon, a recognised leader and expert in the public health and health economics ecosystem, and the entire RWEality team to our group. This combination aligns perfectly with our development strategy and will accelerate our growth and leadership in market access services in France and Europe.”
Bourguignon, founder and CEO of RWEality, added: “Joining Enosium Life Science is a fantastic opportunity for RWEality. Our complementary expertise and shared market vision will enable us to accelerate the value demonstration of our clients’ healthcare products.”
Ella Day
3/4/25
Related Content
Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
Crown Bioscience opens new US model development centre
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …
